Changes in capillary permeability in diabetic patients. 1997

P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
Laboratory of Nutrition and Metabolic Diseases, Jean Verdier Hospital, Paris-Nord University, Bondy, France.

Microangiopathic disorders, characterized by capillary vasodilation and increases in capillary blood flow and permeability, are common in diabetes and can occur before the development of microangiopathic complications. In a study of 163 diabetic patients, capillary permeability, measured by albumin retention (AR), was increased in 39% of patients. AR was increased more frequently in women than in men, and in patients without microangiopathic complications than in patients with complications. Increased AR was significantly associated with insulin-dependent diabetes in male patients. Lymphatic function was abnormal in 72% of patients; this abnormality was often present before AR increased. The pathophysiology of microangiopathy is complex and involves metabolic, haemodynamic, neurological and hormonal factors. Improved control of glycaemia and blood pressure can reduce capillary permeability. In addition, studies with a flavonoid fraction and n-3 polyunsaturated fatty acids suggest that these agents may also be beneficial.

UI MeSH Term Description Entries
D008297 Male Males
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
September 1959, Arzneimittel-Forschung,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
January 1946, Klinische Wochenschrift,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
April 1964, The Journal of pharmacy and pharmacology,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
August 1984, Critical care medicine,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
January 2003, Diabetologia,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
May 1993, Circulation research,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
November 1972, British medical journal,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
December 1972, British medical journal,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
February 1988, No to shinkei = Brain and nerve,
P Valensi, and F Cohen-Boulakia, and J R Attali, and A Behar
January 1991, Diabetes research and clinical practice,
Copied contents to your clipboard!